Skip to main content

EPA proposes methylene chloride ban

30th April 2023

Submitted by:

Andrew Warmington

The US Environmental Protection Agency (EPA) has proposed a ban on most uses of methylene chloride (or dichloromethane) under the Toxic Substances Control Act, on the grounds that exposure can lead to severe health impacts. This makes it the second chemical, after asbestos, to undergo risk management under the reformed process created by the 2016 Frank R. Lautenberg Chemical Safety for the 21st Century Act.

The agency stated that at least 85 people have died from acute exposure to methylene chloride since 1980, mostly workers carrying out home renovation work, including some who were wearing personal protective equipment. Many more have suffered long-term health impacts. Risks have been identified for neurotoxicity, liver effects and cancer from inhalation and dermal exposure.

Methylene chloride is used in consumer applications like aerosol degreasers and brush cleaners for paints and coatings; commercial applications such as adhesives and sealants; and as intermediate. Its use in consumer paint strippers was banned in 2019.

The proposed risk management rule would phase down the manufacturing, processing and distribution of methylene chloride for all consumer uses and most industrial and commercial uses. This would be largely implemented in 15 months, removing about 52% of volume use from the market. The agency said that alternative products with similar costs and efficacy are generally available.

Where the general prohibition will not apply, the EPA is proposing a workplace chemical protection programme with strict exposure limits. This covers uses where methylene chloride is needed to produce chemicals essential to reducing global warming, such as in the production of the refrigerant hydrofluorocarbon 32, and federal aerospace and aviation applications.

Laboratory use would be subject to a workplace chemical protection programme instead of a prohibition. This would limit occupational exposure to an average of 2 ppm over eight hours and 16 ppm over 15 minutes. There are also proposed prohibitions and restrictions regarding facilities abutting certain communities.

Industry association the American Chemistry Council (ACC) criticised the plan saying that it “introduces regulatory uncertainty and confusion” because there are existing exposure limits set by the Occupational Safety & Health Administration. Moreover, it said, methylene chloride is very widely used and there could be wider impacts.

“That scale of reduction in production, that rapidly, could have substantial supply chain impacts if manufacturers have contractual obligations they need to follow through on or if manufacturers decide to cease production entirely,” the ACC warned. ‘These sorts of ripple effects could impact critical uses, including pharmaceutical supply chains.”

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington